Clinical Trial Update: Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Neuromultivit for vertebrogenic radiculopathy has completed, reporting on its safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vertebrogenic Radiculopathy

Drugs mentioned

• Neuromultivit (Vitamin B1 (thiamine) / Vitamin B6 (pyridoxine) / Vitamin B12 (cyanocobalamin))

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Vertebrogenic Radiculopathy L5, S1 | Phase 3 | Status: COMPLETED